Alnylam Pharmaceuticals (NasdaqGS:ALNY) has entered new collaborations with Viz.ai and the American Heart Association to ...

Alnylam Pharmaceuticals is a pioneer in designing therapeutics based on RNA interference, or RNAi, a mechanism that occurs naturally in cells and silences overexpressed genes, which often cause ...

Codexis, Inc. (NASDAQ:CDXS) is one of the 10 Best High-Risk Penny Stocks to Buy Right Now. On March 12, Matt Hewitt of ...

Ellipsis Health partners with PromptWell to boost enrollment in patient care programs, while CaryHealth teams up with ...

Viz.ai, the leader in AI-powered disease detection and care coordination, today announced a partnership with Alnylam ...

Efforts Aimed at Facilitating Earlier Diagnosis, Coordinated Care, and Long-Term Patient Impact in ATTR-CM – − Alnylam to ...

Sarepta Therapeutics is navigating a transition from a profitable rare-disease company to a capital-intensive, multi-platform ...

Significant regulatory milestone marks advancement into clinical-stage development of next-generation RNAi therapy featuring an innovative, ...

In this article, we will take a look at the 12 Best Rebound Stocks to Buy Right Now. On March 20, oil prices rose again, ...

Detailed price information for Phio Pharmaceuticals Corp (PHIO-Q) from The Globe and Mail including charting and trades.

Biopesticides represent a kind of Utopian destination in the landscape of agricultural sustainability. If only they could ...

Balancing nitrogen use is critical for maximizing crop yield while minimizing environmental and economic costs. A new approach integrates drone-based multispectral imaging with machine learning to ...